日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study

美国浆母细胞淋巴瘤的预后和治疗:一项多中心回顾性研究

Hamby, Matthew; Egleston, Brian L; Frosch, Zachary A K; Steiner, Raphael E; Noy, Ariela; Carvajal, Veronica; Chong, Emeline R; Tolu, Seda S; Jean-Louis, Gaston; Amengual, Jennifer E; Patel, Romil; Ahmed, Sairah; Sharp, John; Voorhees, Timothy; Baiocchi, Robert; Ramirez-Gamero, Andres; Castillo, Jorge J; Hamburger, Emily; Dittus, Christopher; Nizamuddin, Imran A; Mehta-Shah, Neha; Thaw Dar, Nyein Nyein; Sandoval-Sus, Jose; Rojek, Alexandra E; Riedell, Peter A; Khan, Niloufer; Danilov, Alexey; Solipuram, Vinod; Rubinstein, Paul G; Ariotti, Anthony; Suneja, Gita; Vartanov, Alexander; Milrod, Charles; Olszewski, Adam J; Smilnak, Gordon; Ayers, Emily; Desai, Sahaj; Rhodes, Joanna M; Magarelli, Gabriella; Feldman, Tatyana; Pellon, Meredith; Aboulafia, David M; Bae, William; Galvez, Carlos; Bhatlapenumarthi, Vineel; Hamadani, Mehdi; Barta, Stefan K

Conditioning, MRD, and NPM1 comutation in the MORPHO trial

MORPHO试验中的条件反射、MRD和NPM1突变

Levis, Mark J; Hamadani, Mehdi; Chen, Yi-Bin

Tildrakizumab for the prophylaxis of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

替拉珠单抗用于预防同种异体造血干细胞移植后的移植物抗宿主病

Runaas, Lyndsey; Fank, Salena; Palen, Katie; Szabo, Aniko; Rein, Lisa E; Ying, Grace; Salzman, Nita; Samanas, Lisa; Abedin, Sameem; Chhabra, Saurabh; Hamadani, Mehdi; Longo, Walter; Shah, Nirav N; Haber, Jennifer; Gradissimo, Ana; Waters, Nicholas; Peled, Jonathan U; Johnson, Bryon; Kearl, Tyce; Drobyski, William R

Financial Toxicity in a Phase I/II Trial of LV20.19 CAR-T Cell for B-cell Malignancies: A Longitudinal, Qualitative Study

LV20.19 CAR-T 细胞治疗 B 细胞恶性肿瘤 I/II 期临床试验中的财务毒性:一项纵向定性研究

Aughey, Elizabeth; Shah, Nirav N; Hillard, Cecilia J; Rentscher, Kelly E; Hamadani, Mehdi; Longo, Walter; Devata, Suma; Knight, Jennifer M; Cusatis, Rachel

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients Aged 65 Years and Above With Myelofibrosis

65岁及以上老年骨髓纤维化患者异基因造血干细胞移植的疗效

Shahzad, Moazzam; Amin, Muhammad Kashif; Irfan, Sohaib; Ahsan, Rania; Qasim, Hana; Javed, Muhammad Jawad; McGuirk, Matthew; Chaudhary, Sibgha Gull; Anwar, Iqra; Yacoub, Abdulraheem; Singh, Anurag K; Hamadani, Mehdi; Mcguirk, Joseph P; Mushtaq, Muhammad Umair

Impact of Measurable Residual Disease Status on Outcomes After HLA-Matched Donor Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia

可测量的残留疾病状态对急性髓系白血病患者接受HLA匹配供者异基因造血干细胞移植后预后的影响

Shahzad, Moazzam; Amin, Muhammad Kashif; Irfan, Sohaib; Vyas, Abhinav; Ahsan, Rania; Chaudhary, Sibgha Gull; Anwar, Iqra; McGuirk, Matthew; Iftikhar, Raheel; Abdelhakim, Haitham; Singh, Anurag K; Hamadani, Mehdi; Mcguirk, Joseph P; Mushtaq, Muhammad Umair

Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study

两种常见GVHD预防方案对肠道微生物群的不同影响:来自BMT CTN 1801研究的结果

Wirbel, Jakob; Saber, Wael; Martens, Michael J; Peled, Jonathan U; Andermann, Tessa M; Fei, Teng; Brooks, Erin F; Doyle, Boryana; Pincus, Nathan B; Jenq, Robert R; Bar, Merav; Bolaños-Meade, Javier; Bratrude, Brandi; Chhabra, Saurabh; Choi, Sung Won; Clark, William; Das, Suman; Elmariah, Hany; Gooptu, Mahasweta; Holtan, Shernan G; Jones, Richard J; Levine, John E; Logan, Brent R; Al Malki, Monzr M; Murthy, Hemant S; Rashidi, Armin; Rezvani, Andrew R; Riches, Marcie L; Runaas, Lyndsey; Sandhu, Karamjeet; Spahn, Ashley; Sung, Anthony D; van den Brink, Marcel R M; Horowitz, Mary M; Hamadani, Mehdi; Kean, Leslie S; Perales, Miguel-Angel; Bhatt, Ami S

Allogeneic Chimeric Antigen Receptor T-Cell Products Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma: Phase I Experience From the ALPHA2/ALPHA Clinical Studies

异基因嵌合抗原受体T细胞产品Cemacabtagene Ansegedleucel/ALLO-501治疗复发/难治性大B细胞淋巴瘤:ALPHA2/ALPHA临床研究的I期经验

Locke, Frederick L; Munoz, Javier L; Tees, Michael T; Lekakis, Lazaros J; de Vos, Sven; Nath, Rajneesh; Stevens, Don A; Malik, Shahbaz A; Shouse, Geoffrey P; Hamadani, Mehdi; Oluwole, Olalekan O; Perales, Miguel-Angel; Miklos, David B; Fisher, Paul W; Feng, Amy; Navale, Lynn; Le Gall, John B; Neelapu, Sattva S

Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

移植后环磷酰胺治疗不匹配无关供者外周血干细胞移植引起的移植物抗宿主病

Al Malki, Monzr M; Bo-Subait, Stephanie; Logan, Brent; Olson, Janelle; Kou, Jianqun; Smith, Sarah; Leckrone, Erin; Wu, Juan; Stefanski, Heather E; Auletta, Jeffery J; Spellman, Stephen R; Malmberg, Craig; Askar, Medhat; Cusatis, Rachel; Shaffer, Brian C; Modi, Dipenkumar; Khimani, Farhad; Gooptu, Mahasweta; Hamadani, Mehdi; Madbouly, Abeer; Maiers, Martin; Fingerson, Stephanie; Cook, Rachel; Ballen, Karen; Loren, Alison; Larkin, Karilyn; Arai, Sally; Qayed, Muna; Choi, Sung Won; Broglie, Larisa; Shaw, Bronwen E; Devine, Steven Michael; Jimenez Jimenez, Antonio Martin

Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703

移植后环磷酰胺治疗改善患者报告结局:BMT CTN 1703 的生活质量评估和 2 年结局

Holtan, Shernan G; Bolaños-Meade, Javier; Al Malki, Monzr M; Wu, Juan; Kitko, Carrie L; Reshef, Ran; Rezvani, Andrew R; Shaffer, Brian C; Solh, Melhem M; Yao, Janny M; Runaas, Lyndsey; Elmariah, Hany; Larkin, Karilyn T; El Jurdi, Najla; Gooptu, Mahasweta; Loren, Alison W; Hall, Aric C; Alousi, Amin M; Jamy, Omer; Clark, William; Kean, Leslie; Bhatt, Ami S; Perales, Miguel-Angel; Applegate, Kristy; Efebera, Yvonne Adeduni; Leifer, Eric; Jones, Richard J; Horowitz, Mary M; Mattila, Deborah; Saber, Wael; Hamadani, Mehdi; Martens, Michael J